St. Jude/Cambridge Heart sales
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical will market Cambridge Heart's HearTwave II microvolt t-wave alternans test to North American primary care and internal medicine physicians under an amendment to the firms' three-year marketing agreement, they announce June 18. Under the original deal, signed in March, St. Jude was only to target electrophysiologists and cardiologists for sales of the product, which is used to stratify patients by risk for implantable defibrillator need (1"The Gray Sheet" March 26, 2007, p. 8). Cambridge Heart's reps, who originally addressed the primary care and internal medicine market, will now support St. Jude's team in all physician markets...
You may also be interested in...
T-Wave Alternans ICD Screening May Gain Traction With St. Jude Pact
St. Jude Medical's endorsement of microvolt t-wave alternans testing under a co-marketing agreement with test maker Cambridge Heart will help accelerate adoption of the technology, which guides appropriate defibrillator patient selection, both companies say
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.